REGENXBIO Inc. (RGNX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US75901B1070
REGENXBIO Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 170.44 m USD |
| Operating income | -161.20 m USD |
| EBIT | -161.07 m USD |
| Net income | -193.88 m USD |
| Diluted EPS – continuing operations | -3.76 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About REGENXBIO Inc.
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
More stocks
- Mega-info Media Co.Ltd. (301102.SZ)
- Shanghai Golden Bridge (603918.SS)
- Wuhan Hvsen Biotechnology Co Ltd (300871.SZ)
- Xiamen Insight Investment Co Ltd (000526.SZ)
- Hangzhou Flariant Co Ltd (605566.SS)
- Hangzhou Huasu Technology Co. Ltd. A (301157.SZ)
- Group Up Industrial Co., Ltd. (6664.TWO)
- Shenyu Communication Technology Inc (300563.SZ)
- MK Restaurant Group Public Company Limited (M.BK)
- Figeac Aero SARL (FGA.PA)
- Amper SA (AMP.MC)
- Boost Run Inc. Class A Common Stock (BRUN)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.